Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of agomelatine on migraine
IRCT20230303057599N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of agomelatine in migraine, sponsored by Tehran University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
agomelatine
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20230303057599N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230303057599N1.